Pharvaris NV (Pharvaris NV) Total Stockholders Equity : $390.40 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pharvaris NV Total Stockholders Equity?

Pharvaris NV's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $390.40 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Pharvaris NV's Book Value per Share for the quarter that ended in Mar. 2024 was $7.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Pharvaris NV's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Pharvaris NV Total Stockholders Equity Historical Data

The historical data trend for Pharvaris NV's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharvaris NV Total Stockholders Equity Chart

Pharvaris NV Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

20.75

116.53

231.59

158.11

418.81

Pharvaris NV Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															138.27	188.22	163.43	418.81	390.40

Pharvaris NV (NAS:PHVS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Pharvaris NV's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(390.401	-	0)	/	53.8167
	=	7.25

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Pharvaris NV's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.13	+	0.076)	/	390.401
	=	0.00

Pharvaris NV Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pharvaris NV's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharvaris NV (Pharvaris NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharvaris NV (NAS:PHVS) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

9EN:Germany

Address

Emmy Noetherweg 2, Leiden, NLD, 2333 BK

Website

https://www.pharvaris.com

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases.